Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis

• Published in: Vascular medicine (London) Vol. 4; no. 2; pp. 67 - 75
• Main Authors: Kanters, Suzan DJM, Banga, Jan-Dirk, Stolk, Ronald P, Algra, Ale
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Thousand Oaks, CA Sage Publications 01.05.1999; Arnold
• Subjects: Associated diseases and complications; Biological and medical sciences; Cerebrovascular Disorders - mortality; Confidence Intervals; Diabetes Mellitus, Type 1 - mortality; Diabetes Mellitus, Type 2 - mortality; Diabetes. Impaired glucose tolerance; Diabetic Angiopathies - mortality; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Global Health; Humans; Incidence; Medical sciences; Myocardial Infarction - mortality; Poisson Distribution; mortality; cardiovascular disease; determinants; diabetes; incidence; Endocrinopathy; Vascular disease; Human; Prognosis; Diabetes mellitus; Mortality; Atherosclerosis; Cardiovascular disease; Complication; Metaanalysis
• ISSN: 1358-836X; 1358-863X; 1477-0377
• DOI: 10.1177/1358836X9900400203

Patients with diabetes mellitus are at increased risk of developing atherosclerotic disease. The extent of this additional risk and its determinants are not well known, but this information is needed for sample-size estimations in intervention studies. Therefore, a meta-analysis of epidemiologic studies on this subject was performed. Medline was searched from 1966 onwards, including the reference lists of all relevant publications. A total of 27 prospective follow-up studies in the English language that allowed calculation of the unadjusted incidence of one of the predefined outcome events were included. The influence of age, sex, type of diabetes, duration of diabetes, year of study, HbA1c, cholesterol level, blood pressure and smoking on these incidences was studied by means of univariate Poisson regression analysis. Overall total mortality was 2.9% per year (95% CI 2.8-3.0; 27 studies), and for death from all vascular causes was 1.4% per year (95% CI 1.3-1.4; 16 studies). Only two studies were found that reported on the incidence of the composite outcome `event death from all vascular causes, non-fatal myocardial infarction, or non-fatal stroke'. In univariate analysis, age, year of study, total cholesterol and systolic blood pressure were positively related to total mortality and death from all vascular causes. After adjustment for age, or limiting the analyses to studies in patients with type 2 diabetes only (n = 11), these relationships remained statistically significant. In conclusion, the overall yearly total mortality in diabetes mellitus is 2.9% and for death from all vascular causes is 1.4%. There are few data on the incidence of composite cardiovascular outcome events.